chr2-189039284-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_000393.5(COL5A2):c.3913G>A(p.Ala1305Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,613,784 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000393.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL5A2 | NM_000393.5 | c.3913G>A | p.Ala1305Thr | missense_variant | 51/54 | ENST00000374866.9 | NP_000384.2 | |
COL5A2 | XM_011510573.4 | c.3775G>A | p.Ala1259Thr | missense_variant | 54/57 | XP_011508875.1 | ||
COL5A2 | XM_047443251.1 | c.3775G>A | p.Ala1259Thr | missense_variant | 56/59 | XP_047299207.1 | ||
COL5A2 | XM_047443252.1 | c.3775G>A | p.Ala1259Thr | missense_variant | 55/58 | XP_047299208.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL5A2 | ENST00000374866.9 | c.3913G>A | p.Ala1305Thr | missense_variant | 51/54 | 1 | NM_000393.5 | ENSP00000364000.3 | ||
COL5A2 | ENST00000618828.1 | c.2752G>A | p.Ala918Thr | missense_variant | 44/47 | 5 | ENSP00000482184.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152146Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000320 AC: 8AN: 249994Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135240
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461638Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 727144
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152146Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74314
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 28, 2022 | Has been reported as a variant of uncertain significance in a patient with bleeding issue, hypermobility, and at least one first degree family member with bleeding diathesis (Fager et al., 2020).; In silico analysis supports that this missense variant does not alter protein structure/function; Not located in the triple helical region, where the majority of pathogenic missense variants occur (Symoens et al., 2012; Stenson et al., 2014); Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 237776); This variant is associated with the following publications: (PMID: 33161638) - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2016 | The p.A1305T variant (also known as c.3913G>A), located in coding exon 51 of the COL5A2 gene, results from a G to A substitution at nucleotide position 3913. The alanine at codon 1305 is replaced by threonine, an amino acid with similar properties. This variant was previously reported in the SNPDatabase as rs372897632. Based on data from ExAC, the A allele has an overall frequency of approximately 0.004% (5/121352). The highest observed frequency was 0.02% (2/10400) of African alleles (Exome Aggregation Consortium (ExAC), Cambridge, MA (URL: http://exac.broadinstitute.org) [Accessed March 15, 2016]). Based on data from the NHLBI Exome Sequencing Project (ESP), the A allele has an overall frequency of approximately 0.01% (1/13006) total alleles studied, having been observed in 0.02% (1/4406) African American alleles. This amino acid position is poorly conserved in available vertebrate species, and threonine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 24, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at